800
Participants
Start Date
September 22, 2020
Primary Completion Date
December 30, 2025
Study Completion Date
December 31, 2025
Bdq, Lzd, Lfx, Dlm, Cfz (9-12 months)
Bdq, Lzd, Lfx, Dlm, Cfz for nine months, with extension to 12 months as needed
Bdq, Lzd, Lfx, Cfz, Cs (9-12 months)
Bdq, Lzd, Lfx, Cfz, Cs for nine months, with extension to 12 months as needed
Bdq, Lzd, Lfx, Z, Dlm (9-12 months)
Bdq, Lzd, Lfx, Z, Dlm for nine months, with extension to 12 months as needed
Partners In Health, Kazakhstan, Almaty
Partners In Health, Lesotho, Maseru
Socios En Salud, Lima
Collaborators (1)
National Institute of Allergy and Infectious Diseases (NIAID)
NIH
Partners in Health
OTHER
Socios En Salud Sucursal, Peru
OTHER
Harvard Medical School (HMS and HSDM)
OTHER